XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Reverse Recapitalization (Tables)
12 Months Ended
Dec. 31, 2021
Business Combination And Asset Acquisition [Abstract]  
Schedule of Merger to the Consolidated Statement of Cash Flows and Consolidated Statement of Stockholders' Equity The following table reconciles the elements of the Merger to the consolidated statements of cash flows and the consolidated statements of stockholders’ equity for the year ended December 31, 2021:

 

(In thousands)

 

Recapitalization

 

Cash proceeds from Rotor, net of redemptions and transaction expenses

 

$

25,359

 

Cash proceeds from PIPE Financing

 

 

220,000

 

Less: Cash payment of transaction expenses - Sarcos

 

 

(16,571

)

Net Cash proceeds from Merger and PIPE financing

 

 

228,788

 

Less: Warrant liabilities assumed

 

 

(8,774

)

Less: Other non-cash net assets assumed

 

 

40

 

Less: Unpaid and previously expensed Merger transaction costs

 

 

(148

)

Net contributions from recapitalization

 

$

219,906

 

Immediately following closing of the Merger, the Company had 137,589,275 shares issued and outstanding of Common Stock. The following table present the number of shares of the Company’s Common Stock outstanding immediately following the consummation of the Merger:

 

 

Number of Shares

 

Rotor Class A Common Stock, outstanding prior to Merger

 

 

27,600,000

 

Rotor Class B Common Stock, outstanding prior to Merger

 

 

6,405,960

 

Class A common stock issued to PIPE Investors

 

 

22,000,000

 

Less: redemption of Rotor Common Stock

 

 

(23,479,970

)

Total shares from Merger and PIPE financing

 

 

32,525,990

 

Recapitalization of Old Sarcos common stock into Class A common stock1

 

 

105,063,285

 

Total shares of Common Stock immediately after the Effective Time

 

 

137,589,275

 

 

The number of Old Sarcos shares was determined from the 21,483,286 shares of Old Sarcos Common Stock warrants, Common Stock and preferred stock outstanding immediately prior to the closing of the Business Combination, which are presented net of the Common and Preferred Stock redeemed, converted at the Exchange Ratio of 5.129222424. This excludes a restricted stock award for 5,129,222 shares that was unvested as of the date of the Merger. All fractional shares were rounded down.